1. Home
  2. ADCT vs HITI Comparison

ADCT vs HITI Comparison

Compare ADCT & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • HITI
  • Stock Information
  • Founded
  • ADCT 2011
  • HITI 2009
  • Country
  • ADCT Switzerland
  • HITI Canada
  • Employees
  • ADCT N/A
  • HITI N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • HITI
  • Sector
  • ADCT Health Care
  • HITI
  • Exchange
  • ADCT Nasdaq
  • HITI Nasdaq
  • Market Cap
  • ADCT 241.0M
  • HITI 217.9M
  • IPO Year
  • ADCT 2020
  • HITI N/A
  • Fundamental
  • Price
  • ADCT $2.97
  • HITI $2.31
  • Analyst Decision
  • ADCT Strong Buy
  • HITI Strong Buy
  • Analyst Count
  • ADCT 5
  • HITI 1
  • Target Price
  • ADCT $7.75
  • HITI $4.50
  • AVG Volume (30 Days)
  • ADCT 694.8K
  • HITI 293.6K
  • Earning Date
  • ADCT 05-14-2025
  • HITI 06-12-2025
  • Dividend Yield
  • ADCT N/A
  • HITI N/A
  • EPS Growth
  • ADCT N/A
  • HITI N/A
  • EPS
  • ADCT N/A
  • HITI N/A
  • Revenue
  • ADCT $75,817,000.00
  • HITI $370,825,186.00
  • Revenue This Year
  • ADCT $9.19
  • HITI $12.43
  • Revenue Next Year
  • ADCT $16.27
  • HITI $11.39
  • P/E Ratio
  • ADCT N/A
  • HITI N/A
  • Revenue Growth
  • ADCT 10.49
  • HITI 7.84
  • 52 Week Low
  • ADCT $1.05
  • HITI $1.57
  • 52 Week High
  • ADCT $4.13
  • HITI $3.62
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 75.65
  • HITI 47.92
  • Support Level
  • ADCT $1.83
  • HITI $2.17
  • Resistance Level
  • ADCT $2.35
  • HITI $2.35
  • Average True Range (ATR)
  • ADCT 0.31
  • HITI 0.08
  • MACD
  • ADCT 0.12
  • HITI -0.02
  • Stochastic Oscillator
  • ADCT 93.03
  • HITI 41.42

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: